Avia Pharma acquires Decem Pharma

Avia Pharma has today completed the acquisition of Decem Pharma.

Decem Pharma is a Finish pharmaceutical company with its own brands with strong market positions, such as Magnecit and Otocur.

The acquisition of Decem Pharma is Avia Pharma’s first acquisition outside of Sweden and part of its strategy to build a northern European pharmaceutical company.

“I am really pleased to be able to announce this deal today. Decem Pharma has over the years built a very strong position in Finland with several strong brands. Decem Pharma will strengthen our presence in Finland considerably and enable us to improve the performance of the group’s products in Finland. The current management will continue to run this successful business, but we will of course make sure to extract both sales and cost synergies” says Jacob Calmvik, CEO of Avia Pharma

“Decem Pharma is excited to join forces with Avia Pharma and continue to expand the business in both Finland and abroad. The deal made strategic sense and we will be able to reap significant benefits from it” says Erno Lehtovirta, Chairman of Decem Pharma

For further information, contact Jacob Calmvik, CEO Avia Pharma, jacob.calmvik@aviapharma.se

__________________________________________________________________________________

About Avia Pharma

Avia Pharma is a fast-growing pharmaceutical company founded by senior executives from the pharmaceutical and pharmacy industry. Since its foundation in 2016, Avia Pharma has been able to grow the company to +20 million EUR in sales. This growth has been achieved by both developing its products and making several acquisitions. Avia Pharma’s product portfolio is focused on 4 areas: Women’s health, Urology, Dermatology and OTC.